报价延迟最少15分钟:2026/03/10 00:31 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
1.16 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-1.60/-0.41
|
|
企业价值
48.58M
|
| 资产负债 |
|
每股账面净值
0.18
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
0
|
|
每股收益
--
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia. |
